Cargando…

Editorial: New molecular targets involved in lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Zhan, Xianquan, Li, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900114/ https://www.ncbi.nlm.nih.gov/pubmed/36755924 http://dx.doi.org/10.3389/fendo.2023.1138849

Ejemplares similares

Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Editorial: Molecular Network Study of Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2020)

Editorial: Systems Biological Aspects of Pituitary Tumors
por: Zhan, Xianquan, et al.
Publicado: (2016)

Editorial: Biomolecular modifications in endocrine-related cancers
por: Zhan, Xianquan, et al.
Publicado: (2023)

The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
por: Ye, Zhen, et al.
Publicado: (2023)

Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics
por: Zhan, Xianquan, et al.
Publicado: (2022)

Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas
por: Li, Na, et al.
Publicado: (2019)

Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2016)

Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors
por: Wen, Siqi, et al.
Publicado: (2021)

The role of protein acetylation in carcinogenesis and targeted drug discovery
por: Yang, Jingru, et al.
Publicado: (2022)

Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis
por: Zheng, Peixian, et al.
Publicado: (2022)

The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
por: Lu, Miaolong, et al.
Publicado: (2019)

Human Pituitary Adenoma Proteomics: New Progresses and Perspectives
por: Zhan, Xianquan, et al.
Publicado: (2016)

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues
por: Qian, Shehua, et al.
Publicado: (2019)

Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas
por: Long, Ying, et al.
Publicado: (2019)

Editorial: Emerging receptors as new targets in health and disease
por: Dam, Julie, et al.
Publicado: (2022)

Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: The way to new therapeutic approaches
por: Leclercq, Guy, et al.
Publicado: (2022)

Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients
por: Cheng, Tingting, et al.
Publicado: (2019)

Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry
por: Qian, Shehua, et al.
Publicado: (2018)

Editorial: Molecular mechanisms of osteoporosis
por: Li, Ziqing, et al.
Publicado: (2023)

ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
por: Zhang, Yao-Hua, et al.
Publicado: (2022)

Editorial: Involvement of Tanycytes in the Neuroendocrine Control of Energy Homeostasis
por: Langlet, Fanny, et al.
Publicado: (2020)

Editorial: Telomeres and Epigenetics in Endocrinology
por: Zhan, Yiqiang, et al.
Publicado: (2019)

Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
por: Zetter, Mario, et al.
Publicado: (2019)

Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting
por: Markelic, M., et al.
Publicado: (2023)

Editorial: New Aspects in Hypogonadism
por: Dwyer, Andrew A., et al.
Publicado: (2020)

Editorial: What's New in Endocrinology?
por: Holly, Jeff M. P., et al.
Publicado: (2019)

Editorial: Lipotoxicity, mitotoxicity, and drug targets
por: Krako Jakovljevic, Nina, et al.
Publicado: (2023)

Editorial: Bone: Endocrine Target and Organ
por: Brunetti, Giacomina, et al.
Publicado: (2017)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Editorial: Progression to Diabetes: Molecular and cellular mechanisms
por: Guillén, Carlos, et al.
Publicado: (2023)

Editorial: Recent advances in molecular and structural endocrinology
por: De Meyts, Pierre, et al.
Publicado: (2023)

Editorial: Genetic, epigenetic and molecular landscaping of puberty
por: Howard, Sasha R., et al.
Publicado: (2023)

Editorial: Insights in diabetes: molecular mechanisms 2022
por: Rao, Gundu H. R.
Publicado: (2023)

Editorial: Molecular modulators of GPCRs signal transduction
por: Vrecl, Milka, et al.
Publicado: (2023)

Editorial: Adipocyte differentiation, pluripotency and molecular mechanisms
por: Huh, Jin Young, et al.
Publicado: (2022)

Editorial: Diabetes and Obesity Effects on Lung Function
por: Chen, Xiao-Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5fqnt8k6soe4p2l657fv8of4he